Results 201 to 210 of about 5,966,929 (265)

Erdheim-Chester manifesting purely as a neurological disease. [PDF]

Arq Neuropsiquiatr
Ramos LLS, Carvalho IR, Santos DFD, Luppi AM, Dornelas BC.   +4 more
europepmc   +1 more source

Vascular Disease, Non‐Steroidal Anti‐Inflammatory Drugs and Risk of Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives A history of vascular disease has been shown to be associated with an increased risk of Parkinson's disease, but this may be due to reverse causation. In addition, non‐steroidal anti‐inflammatory drugs are thought to reduce Parkinson's disease risk, but evidence is inconsistent and confounding by prior vascular disease is possible ...
Clare Wotton, Carol Hermon, Sarah Floud, Gillian Reeves, Isobel Barnes   +4 more
wiley   +1 more source

Rare variation in neurological disease genes and its role in multiple sclerosis mimicry and phenotype. [PDF]

Genome Med
Blackburn NB, McComish BJ, Motyer A, Slimmer JC, Leslie SJ, Broadley SA, Jokubaitis VG, Van Der Walt A, Kermode AG, Lechner-Scott J, Parnell GP, Fabis-Pedrini MJ, Scott RJ, Jackson S, Maltby VE, Charlesworth JC, Burdon KP, Taylor BV, Kilpatrick TJ, Rubio JP.   +19 more
europepmc   +1 more source

Re‐Purposing Sapropterin (Kuvan) for ACTA2‐Related Multisystemic Smooth Muscle Dysfunction Syndrome: A Translational Mechanistic and First‐In‐Human Therapeutic Report

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Multisystemic smooth muscle dysfunction syndrome (MSMDS) is an ultra‐rare, ACTA2‐related disorder characterized by severe cerebrovascular disease, aortic aneurysms, and smooth muscle dysfunction. Using molecular dynamics simulations and in silico drug screening, we identified that sapropterin dihydrochloride (Kuvan) is a candidate capable of ...
Moran Hausman‐Kedem, Noa Bielopolski, Vijai Krishnan, Shane Wald‐Altman, Shelly I Shrian, Omer Bar‐Yosef, Livia Kapusta, Claire Shamber, Patricia L. Musolino, Miguel Weil   +9 more
wiley   +1 more source

Comparative effectiveness of educational interventions in neurological disease for healthcare workers and students: a systematic review. [PDF]

BMJ Open
Veremu M, Jiang Z, Gillespie CS, Roman E, Cook WH, Chauhan RV, Rafati Fard A, Toumbas G, Baig S, Zipser C, Stacpoole S, Tetreault L, Deakin N, Bateman A, Davies BM.   +14 more
europepmc   +1 more source

The current status of knowledge, attitudes, and practices of surgical nurses in post-stroke depression care

Asian Journal of Surgery
Cong Liu, Juan Yang, Hang Jiang, Qiuxiang You   +3 more
doaj   +1 more source

Stage‐Dependent β‐Synuclein Links MRI and Cognitive Decline in Alzheimer's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Synaptic degeneration drives cognitive decline in Alzheimer's disease (AD), but synaptic biomarkers are scarce. Brain‐enriched β‐synuclein emerged as a synaptic damage marker. We investigated its diagnostic, prognostic, and structural correlates across the AD continuum.
Ulaş Ay, Merve Alaylioglu, Erdi Sahin, Sanem Sultan Yoruk Oner, Gulce Iskan, Gulce Cosku Yilmaz Cakan, Gozde Kizilates‐Evin, Emre Hari, Elif Kurt, Erdinc Dursun, Basar Bilgic, Hasmet Hanagasi, Hakan Gurvit, Tamer Demiralp, Duygu Gezen‐Ak, Bedia Samanci   +15 more
wiley   +1 more source

Clinically reported covert cerebrovascular disease and risk of neurological disease: a whole-population cohort of 367 988 people using natural language processing. [PDF]

J Neurol Neurosurg Psychiatry
Iveson MH, Mukherjee M, Davidson EM, Zhang H, Sherlock L, Ball EL, Mair G, Hosking A, Whalley H, Poon MTC, Wardlaw JM, Kent DM, Tobin R, Grover C, Alex B, Whiteley W.   +15 more
europepmc   +1 more source

Comparative Analysis of Choroid Plexus Volume Between MOG Antibody Associated Disease and Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Choroid plexus volume (CPV) has been proposed as a neuro‐immunological marker of multiple sclerosis (MS), but its relevance in myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) remains uncertain. We analyzed CPV in 43 individuals with MOGAD, 48 with MS, and 44 healthy controls using a Bayesian Gaussian mixture modeling ...
Jae‐Won Hyun, Shaun G. Hong, Na Young Park, Su‐Hyun Kim, Ho Jin Kim   +4 more
wiley   +1 more source

Trends in Mendelian randomization in neurological disease research: a bibliometric analysis. [PDF]

Front Neurol
Yin S, Zakeer K, Ma Z, Zhao M, Maimaiti A, Wang Z.   +5 more
europepmc   +1 more source